Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents

被引：37

作者：

Britton, Robert G. ^{[2
]}

Horner-Glister, Emma ^{[1
]}

Pomenya, Odette A. ^{[1
]}

Smith, Ewan E. ^{[3
]}

Denton, Roanne ^{[3
]}

Jenkins, Paul R. ^{[3
]}

Steward, William P. ^{[1
]}

Brown, Karen ^{[1
]}

Gescher, Andreas ^{[1
]}

Sale, Stewart ^{[1
]}

机构：

[1] Univ Leicester, Leicester Royal Infirm, RKCSB, Dept Canc Studies & Mol Med, Leicester LE2 7LX, Leics, England

[2] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 7RH, Leics, England

[3] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2012年 / 54卷

关键词：

Flavonols; AR signalling pathway; Prostate cancer management; CELL-CYCLE ARREST; ANDROGEN RECEPTOR; QUERCETIN; APOPTOSIS; EXPRESSION; EFFICACY; FISETIN; LINES;

D O I：

10.1016/j.ejmech.2012.06.031

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A library of flavonol analogues was synthesised and evaluated as potential anticancer agents against a human prostate cancer cell line, 22rv1. Compounds 3, 8 and 11 (IC50 2.6, 3.3 and 4.0 mu M respectively) showed potent cancer cell growth inhibition, comparable to the lead compound 3',4',5'-trimethoxyflavonol (1) (IC50 3.1 mu M) and superior to the naturally occurring flavonols quercetin (16) and fisetin (22) (both >15 mu M). Results indicate that the 3',4',5'- arrangement of either hydroxy (OH) or methoxy (OMe) residues is important for growth arrest of these cells and that the OMe analogues may be superior to their OH counterparts. Compounds 1, 3, 8 and 11 warrant further investigation as potential agents for the management of prostate cancer. (C) 2012 Elsevier Masson SAS. All rights reserved.

引用

页码：952 / 958

页数：7

共 50 条

[21] Curcumin-Based Anti-Prostate Cancer Agents
Chen, Qiao-Hong
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (02) : 138 - 156
[22] Synthesis and Biological Evaluation of Novel Indomethacin Derivatives as Potential Anti-Colon Cancer Agents
Farrag, Amel Mostafa
ARCHIV DER PHARMAZIE, 2016, 349 (12) : 904 - 914
[23] Synthesis and biological evaluation of novel shikonin ester derivatives as potential anti-cancer agents
Baloch, Shahla Karim
Ling, Li-Jun
Qiu, Han-Yue
Ma, Lin
Lin, Hong-Yan
Huang, Shou-Cheng
Qi, Jin-Liang
Wang, Xiao-Ming
Lu, Gui-Hua
Yang, Yong-Hua
RSC ADVANCES, 2014, 4 (67) : 35588 - 35596
[24] Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents
Alafeefy, Ahmed M.
Ashour, Abdelkader E.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (04) : 541 - 545
[25] Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents
Ohtsu, H
Xiao, ZY
Ishida, J
Nagai, M
Wang, HK
Itokawa, H
Su, CY
Shih, C
Chiang, TY
Chang, E
Lee, YF
Tsai, MY
Chang, CS
Lee, KH
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (23) : 5037 - 5042
[26] Studies toward an amide core for zampanolide mimics as potential anti-prostate cancer agents
Gonzalez, Maricarmen
Chen, Guanglin
Chen, Qiaohong
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
[27] Discovery and biological evaluation of novel CARM1/HDAC2 dual-targeting inhibitors with anti-prostate cancer agents
Liang, Sudong
Geng, Yifei
Niu, Miao-Miao
Zhang, Yan
He, Weiping
Li, Jindong
Yang, Li
Xu, Zhen
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
[28] A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models
Li, Xiang
Chen, Guanglin
Zhang, Xiaojie
Zhang, Qiang
Zheng, Shilong
Wang, Guangdi
Chen, Qiao-Hong
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (17) : 4241 - 4245
[29] Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations
Bao Vue
Zhang, Sheng
Zhang, Xiaojie
Parisis, Konstantinos
Zhang, Qiang
Zheng, Shilong
Wang, Guangdi
Chen, Qiao-Hong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 : 36 - 46
[30] Novel Synthesis and Biological Evaluation of Enigmols as Therapeutic Agents for Treating Prostate Cancer
Garnier-Amblard, Ethel C.
Mays, Suzanne G.
Arrendale, Richard F.
Baillie, Mark T.
Bushnev, Anatoliy S.
Culver, Deborah G.
Evers, Taylor J.
Holt, Jason J.
Howard, Randy B.
Liebeskind, Lanny S.
Menaldino, David S.
Natchus, Michael G.
Petros, John A.
Ramaraju, Harsha
Reddy, G. Prabhakar
Liotta, Dennis C.
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (06): : 438 - 443

← 1 2 3 4 5 →